News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - IPO, Withdrawals
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Aldagen, Inc. (ALDH) Pulls $80.5 Million IPO 4/6/2011
Ikaria Inc. Withdraws IPO, Leaving Arch, Hutch in the Lurch 11/11/2010
Belgium's Taminco Cancels IPO, Cites Poor Market 2/4/2010
Alimera Sciences Cancels IPO 4/9/2009
Epocrates Inc. Cancels IPO 12/16/2008
Aegerion Pharmaceuticals, Inc. Cancels Another IPO 12/15/2008
ChemoCentryx, Inc. Cancels IPO 11/17/2008
CyDex Pharmaceuticals Cancels IPO 10/29/2008
Xanodyne Pharmaceuticals, Inc. Cancels IPO Due to "Market Conditions" 10/27/2008
Aldagen, Inc. Files to Withdraw IPO Plans 10/8/2008
INSYS Therapeutics Files to Withdraw IPO Plans 9/9/2008
Codexis Pharmaceuticals Cancels $100 Million IPO 9/3/2008
Bayhill Therapeutics, Inc. Withdraws IPO Plans 6/30/2008
EDB Singapore and Agency for Science, Technology and Research Release: Singapore Reinforces Position as a Global Site for Pharma & Biotech 6/18/2008
Peplin Inc. Files to Withdraw IPO Plans 6/10/2008
Elixir Pharmaceuticals Withdraws IPO Plans 5/12/2008
MonoSolRx LLC Withdraws IPO Plans 3/28/2008
Light Sciences Oncology, Inc. Withdraws IPO Plans; Cites Market Conditions 2/11/2008
Reliant Pharmaceuticals, Inc. Withdraws IPO Plans 11/21/2007
ZARS Pharma Withdraws Plans for IPO 10/8/2007
Quark Pharmaceuticals Inc. (QURK) Withdraws IPO Filing 7/30/2007